Study of GS-3242 in Participants With HIV-1; Substudy-05
Public ClinicalTrials.gov record NCT07001319. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Umbrella Phase 1b, Open-label, Multi-Cohort Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Novel Antiretrovirals in Participants With HIV-1 Substudy-05: GS-3242
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is part of a master study. The goal of master protocol (GS-US-544-5905, NCT05585307) is to learn how novel antiretrovirals (medicines that stop the virus from multiplying) affect the human immunodeficiency virus-1 (HIV-1) infection in people living with HIV (PWH). Substudy GS-US-544-5905-05 is to learn more about the study drug GS-3242 in PWH.
Study identification
- NCT ID
- NCT07001319
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 27 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 29, 2025 (Actual)
- Primary completion
- Mar 3, 2026 (Actual)
- Completion
- Apr 16, 2026 (Actual)
- Last update posted
- May 11, 2026
2025 – 2026
United States locations
- U.S. sites
- 21
- U.S. states
- 10
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Franco Felizarta, MD | Bakersfield | California | 93301 | — |
| Ruane Clinical Research Group, Inc | Los Angeles | California | 90036 | — |
| Mills Clinical Research | Los Angeles | California | 90069 | — |
| Quest Clinical Research | San Francisco | California | 94115 | — |
| Washington Health Institute | Washington D.C. | District of Columbia | 20017 | — |
| Midland Florida Clinical Research Center, LLC | DeLand | Florida | 32720 | — |
| AIDS Healthcare Foundation - Northpoint | Fort Lauderdale | Florida | 33308 | — |
| Midway Immunology & Research Center, LLC | Ft. Pierce | Florida | 34982 | — |
| BLISS Health | Orlando | Florida | 32803 | — |
| Orlando Immunology Center, PA | Orlando | Florida | 32803 | — |
| Triple O Research Institute, P.A. | West Palm Beach | Florida | 33407 | — |
| Chatham County Health Department | Savannah | Georgia | 31401 | — |
| Indiana University School of Medicine | Indianapolis | Indiana | 46202 | — |
| Be Well Medical Center | Berkley | Michigan | 48072 | — |
| KC CARE Health Center | Kansas City | Missouri | 64111 | — |
| University of Cincinnati College of Medicine | Cincinnati | Ohio | 45267 | — |
| Central Texas Clinical Research | Austin | Texas | 78705 | — |
| Prism Health North Texas | Dallas | Texas | 75208 | — |
| North Texas Infectious Diseases Consultant's, P.A. | Dallas | Texas | 75246 | — |
| AXCES Research Group, LLC | El Paso | Texas | 79902 | — |
| AXCES Research Group, LLC | Salt Lake City | Utah | 84102 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07001319, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 11, 2026 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07001319 live on ClinicalTrials.gov.